XML 153 R65.htm IDEA: XBRL DOCUMENT v3.25.2
Related parties (Details Narrative)
6 Months Ended
Jul. 01, 2025
EUR (€)
May 31, 2025
EUR (€)
May 12, 2025
EUR (€)
Apr. 01, 2025
EUR (€)
Feb. 29, 2024
EUR (€)
Apr. 20, 2023
EUR (€)
Jul. 01, 2022
EUR (€)
Jun. 30, 2025
USD ($)
Jun. 30, 2025
EUR (€)
shares
Jun. 30, 2024
EUR (€)
shares
Mar. 31, 2025
shares
Dec. 31, 2024
EUR (€)
shares
Jul. 31, 2024
shares
Mar. 31, 2024
shares
Dec. 31, 2023
EUR (€)
Jun. 30, 2023
EUR (€)
shares
Other general and administrative costs                 € 51,000              
Depreciation expenses                 14,000              
Insurance cost limited liability                 93,000              
Membership fees                 30,000              
Patent maintenance                 12,000              
Other various minor expenses                 131,000              
Billed paid                 5,000 € 5,000            
Compensation expense                 € 352,364 232,768            
Vested shares | shares                 803,524     456,098        
Paid in cash                 € 3,982     € 4,000        
Accrued expenses to related parties                 230,712     1,031,345        
Amended and Restated OSR License Agreement [Member]                                
Upfront fee                 € 250,000              
Other Commitments, Description               The Company is also obligated to carry out its development activities using qualified and experienced professionals and a sufficient level of resources. In particular, consistent with the terms of the Original OSR License Agreement, the ARLA continues to require the Company to invest (a) at least €5,425,000 with respect to the development of the licensed products, and (b) at least €2,420,000 with respect to the manufacturing of such licensed products (subject to certain adjustments). The Company is also obligated to carry out its development activities using qualified and experienced professionals and a sufficient level of resources. In particular, consistent with the terms of the Original OSR License Agreement, the ARLA continues to require the Company to invest (a) at least €5,425,000 with respect to the development of the licensed products, and (b) at least €2,420,000 with respect to the manufacturing of such licensed products (subject to certain adjustments).              
Sublicense Agreement [Member]                                
Taxes and licenses           € 875,000                    
Amendment to OSR Amendedand Restated License Agreement [Member]                                
Cash consideration                 € 200,000              
Amendment to OSR Amendedand Restated License Agreement [Member] | First Solid Cancer Indication Option Fee [Member]                                
Operating costs and expenses                 11,800,000              
Amendment to OSR Amendedand Restated License Agreement [Member] | Second Solid Cancer Indication Option Fee [Member]                                
Option fee                 1,000,000.0              
Amended and Restated License Agreement [Member] | Second Solid Cancer Indication Option Fee [Member]                                
Option fee                 400,000              
First Indication [Member]                                
Future option fees                 1,000,000.0              
Second Indication [Member]                                
Future option fees                 500,000              
Third Indication [Member]                                
Future option fees                 300,000              
American Depository Shares [Member]                                
Shares received | shares                     856,602     72,908    
Pierluigi Paracchi [Member]                                
Gross amount                 € 0 168,000           € 168,000
Gross amount                   336,000            
Non qualified shares received | shares                 80,000              
Social contribution amount                 € 307,000 300,000            
Pierluigi Paracchi [Member] | Trattamento Di Fine Rapporto [Member]                                
Social contribution amount                 € 364,000 357,000            
Pierluigi Paracchi [Member] | American Depository Shares [Member]                                
Shares received | shares                 120,000              
Dr Carlo Russos LLC [Member]                                
Gross amount                 € 0     € 260,000     € 260,000  
Non qualified shares received | shares                 65,000              
Compensation expense                 € 226,379 226,379            
Dr Carlo Russos LLC [Member] | American Depository Shares [Member]                                
Shares received | shares                         100,000      
Richard Slansky [Member]                                
Compensation expense                 399,673 399,673            
Related Party [Member] | OSR Sponsor Research Agreement [Member]                                
Payments to acquire                 500,000              
Studio Legale Lexia [Member]                                
Accrued expenses to related parties                 10,070              
Pierluigi Paracchi [Member]                                
Gross salary       € 451,560                        
Percentage of annual bonus       40.00%                        
Director [Member] | Pierluigi Paracchi [Member]                                
Issued invoices   € 45,000                            
Naldini [Member]                                
Issued invoices                 50,000 50,000            
Annual fee     € 50,000       € 100,000                  
Dr.Gentner [[Member]                                
Issued invoices                 € 22,500 22,500            
Annual fee             € 22,500                  
One time fee payment         € 15,000                      
Dr.Gentner [[Member] | Subsequent Event [Member]                                
Agreement term description The agreement will remain in effect for a fixed term of one (1) year, from July 1, 2025, through June 30, 2026.                              
Dr.Gentner [[Member] | Maximum [Member] | Subsequent Event [Member]                                
Annual compensation € 45,000                              
Dr.Gentner [[Member] | Minimum [Member] | Subsequent Event [Member]                                
Annual compensation € 22,500                              
Dr Carlo Russos LLC [Member]                                
Percentage of annual bonus               30.00% 30.00%              
Gross amount                 € 329,000 € 329,000            
Annual gross salary | $               $ 500,000                
Richard Slansky [Member]                                
Percentage of annual bonus               30.00% 30.00% 50.00%            
Gross amount                 € 98,832             € 49,416
Gross amount                 243,000 € 243,000            
Annual compensation | $               $ 375,000                
Vested shares | shares                   7,669           15,338
Vested amount                   € 23,998           € 47,997
Paid in cash                   18,531           45,902
Bonus amount accrued                   108,000            
Accrued performance bonuses                 € 0              
Richard Slansky [Member] | Finance Employee One [Member]                                
Paid in cash                   3,089           2,196
Richard Slansky [Member] | Finance Employee Two [Member]                                
Paid in cash                   1,853           € 1,318
Richard Slansky [Member] | Finance Employee Three [Member]                                
Paid in cash                   € 1,235